Skip to content

From Spin-outs to the Future of Life Sciences. Insight from BioFocus 2025

Early in June 2025, we had the pleasure of attending the BioFocus 2025 conference at the Catalyst building, nestled in the heart of the Helix Science Park in Newcastle upon Tyne. Hosted by Bionow, this annual event brought together life sciences professionals, innovators, and advocates from across the North of England—and what a day it was.

With sunshine pouring through the expansive glass atrium of the Catalyst, located at the Helix in Newcastle, the scene was set for a day that was equal parts inspirational and thought-provoking. This year’s theme, The Future of the Industry, resonated deeply with the conversations and connections that unfolded throughout the day. An event organised by the team at BioNow.

Article contents
    Add a header to begin generating the table of contents

    The Strength of the North East Life Sciences Ecosystem

    The day began with the keynote from Clare Trippett titled “Manufacturing the Future: The North East’s Life Sciences Ecosystem”. Clare painted a compelling picture of a region on the rise—home to over 1,000 life sciences companies and boasting 149% growth in the pharmaceutical sector over the past five years. Her presentation echoed something we at Arttia Creative are acutely aware of: that innovation is thriving in the North East of the UK.

    Significant Challenges Remain with Life Sciences Investment

    However, it was rightly highlighted that this growth isn’t without its challenges.

    One of the most pressing was investment.

    The stark funding divide between the North and South of the UK. In 2024, Tyne and Wear secured just £2.6 million in health-related funding, compared to the staggering £902 million allocated to London.

    The numbers speak volumes, setting the stage for a day of honest, solutions-focused discussion. But nobody on stage had any answers. At Arttia Creative, we know the secret to moving investment from London to the North.

    Insight-from-BioFocus-2025-2
    Insight-from-BioFocus-2025-3

    The Future Life Sciences in the North East of the UK

    Following the keynote, the “State of the Nation” panel discussion, chaired by Michelle Duggan, brought forward a powerful dialogue around the structural issues facing life sciences in our region.

    Panellists, including Dr. Dan Todd, Heather Allinson, Richard Hall, and Helen Brain, didn’t hold back. They tackled what many of us already know to be true: we have a scale-up problem.

    While the North East produces remarkable university spin-outs and early-stage ventures, the growth trajectory often falters. Why? Because, as one panellist put it, “rungs are missing on the funding ladder.” Companies often find themselves caught between early-stage support and the larger-scale growth capital they desperately need.

    This isn’t just a regional frustration—it’s a national economic inefficiency. High-risk, high-reward innovations can’t thrive on early investment alone. They need more continuity, more risk-tolerant capital, and more regional funding structures that reflect the value being generated in a specific North East region of the UK.

    Insight-from-BioFocus-2025-4

    At Arttia Creative, we directly understand the challenges within the Life Sciences industry.

    As a dedicated life sciences marketing agency operating nationally and internationally, we partner with many ambitious early-stage life science, biotech, and healthcare innovators. Whether we’re supporting a medical device company with professional medical website design or helping a university spin-out refine their brand and digital presence, we see the same bottlenecks our panellists described.

    Communication is key
    From a communications perspective, we also see an opportunity. The more clearly companies can articulate their vision, science, and market potential, the better positioned they are to advance to the next funding rung. This is where strategic life sciences and healthcare, creative content marketing, and compelling life science branding have a real commercial impact.

    Insight-from-BioFocus-2025-half-3
    Insight-from-BioFocus-2025-half-2
    Insight-from-BioFocus-2025-half-4

    A Regional Life Sciences Future, built collaboratively alongside significant mindset changes

    Something interesting was that having these conversations in a building like the Catalyst. It’s more than just an architectural landmark—it’s a symbol of the North East’s of the UK's life sciencees ambitions.

    It also reaffirmed what we at Arttia Creative have always known: that great science needs great storytelling and inspiring imagery. And that creative and digital life sciences and healthcare communications and marketing—when delivered correctly—can bridge the gap between innovation and investment.

    Insight-from-BioFocus-2025-6

    Life Sciences - Looking Ahead - We know how to help

    BioFocus 2025 wasn’t just about identifying challenges. It was about harnessing collaborative strengths to drive change. It was about building bridges—between universities and industry, between science and communications, and between ideas and global impact.

    As Arttia Creative continue to support healthcare and life science companies with story telling, branding, website design, creative ideas, digital and communications strategy, we remain committed to amplifying the incredible work that life sciences companies deliver.

    Insight-from-BioFocus-2025-5

    The Secret to Fixing the North East Life Sciences Investment Problem

    With over 17 years of experience collaborating with national and international life sciences companies, we possess a comprehensive understanding of the challenges they encounter and the ways Arttia Creative effectively addresses them.

    This perspective allows us to remain somewhat distanced from the immediate complexities of spin-outs or start-ups; we recognise the necessity for these entities to effectively present both their scientific innovations and business strategies in order to secure the long-term investment they require.

    We have identified and are equipped to tackle the challenge of connecting the North East region with potential investors. Our expertise enables us to reshape the discourse surrounding spin-out investment.

    Contact us to unlock the secret to fixing the North East Life Sciences Investment Problem.

    The Takeaway.

    The future of the industry is bright. And it’s being shaped—in part—right here at Arttia Creative. We help life sciences, biotech, pharma and a wide range of healthcare companies to reach further, tell their story, build a brand and grow profitable companies and provide life changing innovation.

    Let's talk.

    Belinda signature scan transparent

    Belinda White | Creative Director

    Scroll To Top